US risks losing measles elimination status as international experts prepare April 2026 review

The United States is on the verge of losing a milestone it achieved more than two decades ago: measles elimination status. Public health authorities warn that the country may soon be deemed to have sustained transmission again, a symbolic but alarming sign of how far vaccination coverage and outbreak control have slipped.

The key issue is whether a single chain of measles has spread uninterrupted in the United States for at least 12 months. That threshold is central to how elimination is evaluated, and experts say the current outbreak picture is increasingly consistent with the criteria for losing the designation.

The outbreak that raised the most concern began in West Texas in January 2025 and later spread to other states. Scientists and public health teams have been working to determine whether more recent outbreaks in places including Utah, Arizona and South Carolina are linked to that same chain.

In 2025, U.S. health officials confirmed 2,242 measles cases across 44 states, the highest total since 1991, along with nearly 50 separate outbreaks. Epidemiologists say that scale reflects deeper vulnerabilities: pockets of low vaccination, uneven access to care and a rise in misinformation-driven hesitancy.

The Pan American Health Organization is expected to review the U.S. situation in April 2026, with a meeting scheduled for April 13. The outcome is described as largely symbolic, but experts argue it matters because it signals whether the conditions that once stopped measles from spreading widely have eroded.

Tracking and containing measles can be costly and labor-intensive. Health departments must perform rapid contact tracing, notify schools and clinics, and coordinate isolation and vaccination efforts. Researchers say even a single measles case can cost public agencies tens of thousands of dollars once staffing and response operations are included.

Genetic sequencing offers clues about whether outbreaks share a common origin. Investigators have found the same measles strain in multiple places across North America, including U.S. states as well as Canada and Mexico, though measles mutates slowly, which can make definitive linking harder.

Many specialists say the most important point is not the label but the trend: measles is exploiting gaps in immunization and public health infrastructure. Regardless of the April decision, experts warn the continent faces a growing measles problem that will persist unless vaccination rates rise and outbreak response capacity is strengthened.